RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Treatment for delaying conversion of the first demyelinating event to Multiple Sclerosis: a cochrane review on use of recombinant interferon beta or glatiramer acetate
2005-01-01 M. CLERICO; F. FAGGIANO; J. PALACE; G. RICE; M. TINTOR; L. DURELLI
Treatment for delaying conversion of the first demyelinating event to Multiple Sclerosis: a cochrane review on use of recombinant interferon beta or glatiramer acetate
2005-01-01 M. CLERICO; G. RICE; M. TINTORE' SUBIRANA; F. FAGGIANO; J. PALACE; L. DURELLI
Treatment response indicators in multiple sclerosis. Persistence of mri activity during first months of immune-modulating drug treatment is predictive of persistence of clinical disease activity over the long term
2005-01-01 L. DURELLI; P. BARBERO; M. CLERICO; B. FERRERO; G. CONTESSA; A. RICCI; E. VERSINO; G. GIULIANI; E. MONTANARI; THE OPTIMS STUDY GROUP
Treatment response to interferon beta: cytokine, chemokine, and chemokine receptor mRNA levels in peripheral blood of multiple sclerosis patients correlate with interferon dose
2008-01-01 Giulia Contessa; Chiara Rivoiro; Angele Cucci; Marinella Clerico; Pierangelo Barbero; Bruno Ferrero; Paolo Ripellino; Daniela Viglietti; Luca Durelli
TYPE 1 INTERFERON RECEPTOR (IFNA-R1). EXPRESSING TH17 LYMPHOCYTES ARE INCREASED DURING MS RELAPSES AND ARE SELECTIVELY INTHBITED BY IFNβ
2008-01-01 L. DURELLI; L. CONTI; M. CLERICO; G. CONTESSA; C. RIVOIRO; A. TAVELLA; E. PICCO; D. VIGLIETTI. A. GHEZZI; M. ZAFFARONI; F. NOVELLI
Ultrasound-guided botulinum toxin-A for sialorrhea: a 2-year prospective study
2015-01-01 Artusi, CA; De Mercanti, S; Busso, M; Tinivella, M; Clerico, M; Durelli, L; Barbero, P
Using biological (mxa protein or il-10 mrna level) or mri indicators for assessing treatment response to interferon-beta
2006-01-01 G. CONTESSA; M. CLERICO; P. BARBERO; B. FERRERO; M.A. CUCCI; L. DELFICO; E. VERSINO; G. GIULIANI; E. MONTANARI; L. DURELLI; FOR THE OPTIMS STUDY GROUP
Validation of treatment response indicators for Multiple Sclerosis: comparison of a biological (mxa protein level) and a mri indicator
2006-01-01 L. DURELLI; P. BARBERO; B. FERRERO; A. RICCI; M. CLERICO; FOR THE OPTIMS STUDY GROUP
Which is the best indication to early treat with interferon beta the clinicaly isolated syndromes based on the clinical onset? a Cochrane metanalysis
2009-01-01 Marinella Clerico; Fabrizio Faggiano; Jacqueline Palace; Maria-Tintore' Subirana; Luca Durelli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 109
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 109
Data di pubblicazione
- 2010 - 2017 24
- 2003 - 2009 85
Editore
- Springer-Verlag 36
- Lippincot Williams and Wilkins 12
- Antonio Federico 7
- SAGE publications 7
- Robert A. Gross 6
- SAGE Pubblications 5
- Lippincott Williams and Wilkins 4
- SAGE Publications 4
- Springer 4
- Springer Verlag-Italia 3
Rivista
- JOURNAL OF NEUROLOGY 2
Keyword
- Active learning 1
- Cooperative learning 1
- Flipped classroom 1
- Global education 1
- Global university 1
- INTERFERONI 1
- SCLEROSI MULTIPLA 1
- Student centered teaching methods 1
- TH17 1
- TH22 1
Lingua
- eng 109
Accesso al fulltext
- no fulltext 107
- open 2